Literature DB >> 23424008

Elastin-based molecular MRI of liver fibrosis.

Josef Ehling1, Matthias Bartneck, Viktor Fech, Britta Butzbach, Richard Cesati, Rene Botnar, Twan Lammers, Frank Tacke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23424008     DOI： 10.1002/hep.26326

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  16 in total

1.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

3.  Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis.

Authors:  Qinxue Sun; Maike Baues; Barbara M Klinkhammer; Josef Ehling; Sonja Djudjaj; Natascha I Drude; Christoph Daniel; Kerstin Amann; Rafael Kramann; Hyojin Kim; Julio Saez-Rodriguez; Ralf Weiskirchen; David C Onthank; Rene M Botnar; Fabian Kiessling; Jürgen Floege; Twan Lammers; Peter Boor
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

Review 4.  Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Authors:  Natalie J Torok; Jonathan A Dranoff; Detlef Schuppan; Scott L Friedman
Journal:  Hepatology       Date:  2015-03-10       Impact factor: 17.425

5.  Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.

Authors:  M J Nielsen; J Lehmann; D J Leeming; R Schierwagen; S Klein; C Jansen; C P Strassburg; F Bendtsen; S Møller; T Sauerbruch; M A Karsdal; A Krag; J Trebicka
Journal:  Dig Dis Sci       Date:  2015-07-03       Impact factor: 3.199

Review 6.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

7.  CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.

Authors:  Josef Ehling; Matthias Bartneck; Xiao Wei; Felix Gremse; Viktor Fech; Diana Möckel; Christer Baeck; Kanishka Hittatiya; Dirk Eulberg; Tom Luedde; Fabian Kiessling; Christian Trautwein; Twan Lammers; Frank Tacke
Journal:  Gut       Date:  2014-02-21       Impact factor: 23.059

Review 8.  Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Authors:  Zhiming Li; Jihong Sun; Xiaoming Yang
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

9.  Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis C.

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Masaki Kato; Yoshihito Yoshida; Keigo Suetani; Yohei Noguchi; Moriaki Hatsugai; Kazunari Nakahara; Hiroki Ikeda; Minoru Kobayashi; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Fumio Itoh; Shiro Maeyama; Shigeru Sase; Michihiro Suzuki
Journal:  Int J Mol Sci       Date:  2014-01-14       Impact factor: 5.923

Review 10.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.